Does Selective Serotonin Reuptake Inhibitors Ssri Interact with Sumatriptan Succinate?
Selective Serotonin Reuptake Inhibitors Ssri and Sumatriptan Succinate have a major drug interaction according to U.S. FDA drug labeling data. Cases of life-threatening serotonin syndrome have been reported during combined use of SSRIs and triptans. The mechanism involves additive serotonergic effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Major
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Selective Serotonin Reuptake Inhibitors Ssri and Sumatriptan Succinate occurs because additive serotonergic effects. Clinically, this means cases of life-threatening serotonin syndrome have been reported during combined use of ssris and triptans. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.
What To Tell Your Doctor or Pharmacist
If you are taking Selective Serotonin Reuptake Inhibitors Ssri and your doctor is considering prescribing Sumatriptan Succinate (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider